Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib in early stage head and neck and non-small cell lung cancers
NCT00058006Phase 2Completed
- Sponsor
- Northwestern University
- Start
- Sep 2002
- Primary completion
- Dec 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in head and neck cancer (HNC), non-small cell lung cancer (NSCLC), sponsored by Northwestern University. Started Sep 2002; status: completed.
02
Drugs
celecoxib
03
Conditions
head and neck cancer (HNC)non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00058006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058006.